Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.

Hoozemans JJ, Veerhuis R, Rozemuller JM, Eikelenboom P.

CNS Neurol Disord Drug Targets. 2011 Feb;10(1):57-67. Review.

PMID:
21143138
2.

Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.

Gouw AA, Seewann A, Vrenken H, van der Flier WM, Rozemuller JM, Barkhof F, Scheltens P, Geurts JJ.

Brain. 2008 Dec;131(Pt 12):3286-98. doi: 10.1093/brain/awn265. Epub 2008 Oct 16.

PMID:
18927145
3.

Distinct genetic forms of frontotemporal dementia.

Seelaar H, Kamphorst W, Rosso SM, Azmani A, Masdjedi R, de Koning I, Maat-Kievit JA, Anar B, Donker Kaat L, Breedveld GJ, Dooijes D, Rozemuller JM, Bronner IF, Rizzu P, van Swieten JC.

Neurology. 2008 Oct 14;71(16):1220-6. doi: 10.1212/01.wnl.0000319702.37497.72. Epub 2008 Aug 13.

PMID:
18703462
4.

Cyclooxygenase-1 and -2 in the different stages of Alzheimer's disease pathology.

Hoozemans JJ, Rozemuller JM, van Haastert ES, Veerhuis R, Eikelenboom P.

Curr Pharm Des. 2008;14(14):1419-27. Review.

PMID:
18537664
5.

Activation of the unfolded protein response in Parkinson's disease.

Hoozemans JJ, van Haastert ES, Eikelenboom P, de Vos RA, Rozemuller JM, Scheper W.

Biochem Biophys Res Commun. 2007 Mar 16;354(3):707-11. Epub 2007 Jan 17.

PMID:
17254549
6.

Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology.

Hoozemans JJ, Veerhuis R, Rozemuller JM, Eikelenboom P.

Int J Dev Neurosci. 2006 Apr-May;24(2-3):157-65. Epub 2005 Dec 27. Review.

PMID:
16384684
7.

The unfolded protein response is activated in Alzheimer's disease.

Hoozemans JJ, Veerhuis R, Van Haastert ES, Rozemuller JM, Baas F, Eikelenboom P, Scheper W.

Acta Neuropathol. 2005 Aug;110(2):165-72. Epub 2005 Jun 23.

PMID:
15973543
8.

Neonatal lactic acidosis, complex I/IV deficiency, and fetal cerebral disruption.

van Straaten HL, van Tintelen JP, Trijbels JM, van den Heuvel LP, Troost D, Rozemuller JM, Duran M, de Vries LS, Schuelke M, Barth PG.

Neuropediatrics. 2005 Jun;36(3):193-9.

PMID:
15944905
9.

Neuroinflammation in Alzheimer's disease and prion disease.

Eikelenboom P, Bate C, Van Gool WA, Hoozemans JJ, Rozemuller JM, Veerhuis R, Williams A.

Glia. 2002 Nov;40(2):232-9. Review.

PMID:
12379910
10.

Microglia and neurodegeneration.

Rozemuller JM, van Muiswinkel FL.

Eur J Clin Invest. 2000 Jun;30(6):469-70. Review. No abstract available.

PMID:
10849012
11.

Microglia, amyloid and dementia in alzheimer disease. A correlative study.

Arends YM, Duyckaerts C, Rozemuller JM, Eikelenboom P, Hauw JJ.

Neurobiol Aging. 2000 Jan-Feb;21(1):39-47.

PMID:
10794847
12.

Inflammation and Alzheimer's disease: relationships between pathogenic mechanisms and clinical expression.

Eikelenboom P, Rozemuller JM, van Muiswinkel FL.

Exp Neurol. 1998 Nov;154(1):89-98. Review.

PMID:
9875271
13.

Cellular and substrate adhesion molecules (integrins) and their ligands in cerebral amyloid plaques in Alzheimer's disease.

Eikelenboom P, Zhan SS, Kamphorst W, van der Valk P, Rozemuller JM.

Virchows Arch. 1994;424(4):421-7.

PMID:
7515758
14.

Activated microglia and cerebral amyloid deposits in Alzheimer's disease.

Rozemuller JM, van der Valk P, Eikelenboom P.

Res Immunol. 1992 Jul-Aug;143(6):646-9. Review. No abstract available.

PMID:
1455057
15.

Distribution pattern and functional state of complement proteins and alpha 1-antichymotrypsin in cerebral beta/A4 deposits in Alzheimer's disease.

Eikelenboom P, Hack CE, Kamphorst W, Rozemuller JM.

Res Immunol. 1992 Jul-Aug;143(6):617-20. Review. No abstract available.

PMID:
1455052
16.

Cytokines and inflammatory proteins in Alzheimer's disease.

Berkenbosch F, Biewenga J, Brouns M, Rozemuller JM, Strijbos P, van Dam AM.

Res Immunol. 1992 Jul-Aug;143(6):657-63. Review. No abstract available.

PMID:
1280851
18.

Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients.

Van Nostrand WE, Wagner SL, Shankle WR, Farrow JS, Dick M, Rozemuller JM, Kuiper MA, Wolters EC, Zimmerman J, Cotman CW, et al.

Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2551-5.

20.

Cerebral amyloid plaques in Alzheimer's disease but not in scrapie-affected mice are closely associated with a local inflammatory process.

Eikelenboom P, Rozemuller JM, Kraal G, Stam FC, McBride PA, Bruce ME, Fraser H.

Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;60(5):329-36.

PMID:
1685040
21.
22.

A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition.

Rozemuller JM, Eikelenboom P, Stam FC, Beyreuther K, Masters CL.

J Neuropathol Exp Neurol. 1989 Nov;48(6):674-91.

PMID:
2677252
23.

Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family.

Rozemuller JM, Eikelenboom P, Pals ST, Stam FC.

Neurosci Lett. 1989 Jul 3;101(3):288-92.

PMID:
2549464
24.

Complement activation in amyloid plaques in Alzheimer's dementia.

Eikelenboom P, Hack CE, Rozemuller JM, Stam FC.

Virchows Arch B Cell Pathol Incl Mol Pathol. 1989;56(4):259-62.

PMID:
2565620
25.

Lack of evidence for dysfunction of the blood-brain barrier in Alzheimer's disease: an immunohistochemical study.

Rozemuller JM, Eikelenboom P, Kamphorst W, Stam FC.

Neurobiol Aging. 1988 Jul-Aug;9(4):383-91.

PMID:
3185857
26.

No evidence for involvement of plasma proteins or blood-borne cells in amyloid plaque formation in scrapie-affected mice. An immunohistoperoxidase study.

Eikelenboom P, Scott JR, McBride PA, Rozemuller JM, Bruce ME, Fraser H.

Virchows Arch B Cell Pathol Incl Mol Pathol. 1987;53(4):251-6.

PMID:
2890238
27.

Role of microglia in plaque formation in senile dementia of the Alzheimer type. An immunohistochemical study.

Rozemuller JM, Eikelenboom P, Stam FC.

Virchows Arch B Cell Pathol Incl Mol Pathol. 1986;51(3):247-54.

PMID:
2874657

Supplemental Content

Loading ...
Support Center